D.med Healthcare and Hebei Changshan Biomedical Pharmaceutical set up Joint Venture

D.Med Healthcare GmbH & Co. KG and Hebei Changshan Pharmaceutical (Hongkong) Co. Ltd., 100% subsidiary of the stock-listed Chinese manufacturer of pharmaceutical products, Hebei Changshan Biomedical Pharmaceutical Co. Ltd. (Shenzhen Stock Exchange / SIN 300255:CH), announce the set-up of a joint venture aiming at the production and marketing of Heparin formulations. TAGS Press ReleaseAdquisitionsGrowthHaemodialysis MarketGlobalDialysis…